Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sarcoma 2Sarcoma, Synovial 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1Neurofibrosarcoma 1Neuroblastoma 1Lymphoma, Large-Cell, Anaplastic 1Localized Extraskeletal Ewing Sarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Ganglioneuroblastoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Central Nervous System Neoplasms 1

Interventions

X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5tazemetostat 4Vincristine 4Specimen Handling 4Nuclear Medicine Department, Hospital 4Cyclophosphamide 4Cisplatin 4Radiotherapy 3Methotrexate 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Carboplatin 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2Vemurafenib 2Temozolomide 2Leucovorin 2LY3023414 2ribociclib 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Rhabdoid Tumor × Razoxane × Clear all
NCT00084838 2015-12-24

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Dana-Farber Cancer Institute

Phase 2 Completed
25 enrolled 24 charts
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡